AMRN FY 2014 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$338M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+105.7% YoY

Gross Profit

$34M62.2% margin

Operating Income

-$96M-177.0% margin

Net Income

-$56M-104.0% margin

EPS (Diluted)

$-7.20

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$72M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$171M

Total Liabilities

$260M

Stockholders' Equity

-$88M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$26M	+105.7%
Gross Profit	$34M	$14M	+133.5%
Operating Income	-$96M	-$182M	+47.3%
Net Income	-$56M	-$166M	+66.1%